News

Gladstone in the News December 4, 2024

For Systems Biologist Nevan Krogan, Effective Research Means Breaking Down Silos

Cell Press—Gladstone Investigator Nevan Krogan, who was selected as one of the Cell Press 50 Scientists that Inspire, discusses how new technologies can break down barriers in research and reveal more commonalities across different disease areas than currently known.

Gladstone Experts Krogan Lab

Gladstone in the News November 26, 2024

AI Reveals Alzheimer’s Subtle, Invisible Warning Signs

StudyFinds—Scientists in Jorge Palop’s lab have developed a cutting-edge technology that could transform how we identify Alzheimer’s years before traditional symptoms become obvious.

Gladstone Experts Alzheimer’s Disease Neurological Disease Palop Lab

Article November 26, 2024

Machine Learning Reveals Behaviors Linked with Early Alzheimer’s, Points to New Treatments

A team of Gladstone scientists used a new video-based tool to pinpoint otherwise-undetectable signs of early disease.

News Release Research (Publication) Alzheimer’s Disease Dementia Palop Lab AI Disease Models

Gladstone in the News November 21, 2024

Why Immunotherapy Still Holds So Much Potential

Drug Discovery World—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, is featured for his innovative work using CRISPR genome editing to develop better cellular therapies for cancer, silencing genes that cause immune cells to become exhausted and activating genes that help them be more effective.

Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing

Gladstone in the News November 18, 2024

Brain Cells Boost Damage Caused by Alzheimer’s Risk Variant

Labroots—Gladstone scientist Yadong Huang comments on his recent study that shows how microglia and APOE4 interact to promote important aspects of Alzheimer’s disease.

Gladstone Experts Alzheimer’s Disease Neurological Disease Huang Lab

Gladstone in the News November 14, 2024

Learning the Language of DNA

Science—In this Perspective article in Science, Gladstone investigator Christina Theodoris shares insights on a new AI model known as Evo that can deduce how bacterial and viral genomes operate—and then use that information to design new proteins and even whole microbial genomes. (Subscription required.)

Gladstone Experts Theodoris Lab AI

Article November 14, 2024

Gladstone President Deepak Srivastava Named 2024 Distinguished Citizen by Commonwealth Club World Affairs

Srivastava is recognized for his organizational leadership, scientific innovation, and impact on the future of medicine.

Awards Srivastava Lab

Article November 11, 2024

Highlighting Native American Scientists

Learn more about these indigenous scientists who’ve made an impact on their fields

Communications Diversity

Gladstone in the News November 8, 2024

Unraveling COVID’s Pernicious Role in Brain Fog and Clotting

Bloomberg—Katerina Akassoglou, a neurovascular brain immunologist at Gladstone, and her team discovered that beyond serving as the virus’s “key” to enter cells, spike binds with a blood clotting factor called fibrinogen, causing a cascade of events that contribute to the neurological symptoms of long COVID.

COVID-19 Akassoglou Lab

Gladstone in the News November 8, 2024

Heart Defects Affect 40,000 US Babies Every Year—But Cutting Edge AI and Stem Cell Tech Will Save Lives and Even Cure Them in the Womb

New York Post—Top health researchers from the Murdoch Children’s Research Institute in Australia have teamed with those from Gladstone Institutes in San Francisco on a new program to develop cutting-edge technologies to treat the underlying causes of childhood heart disease more effectively.

Institutional News Cardiovascular Disease

Article November 6, 2024

Nasal Swab Tests Predict COVID-19 Disease Severity, Study Finds

Researchers discovered that the presence of autoantibodies in the nose can help fight off the virus more effectively.

Research (Publication) COVID-19 Infectious Disease Roan Lab

Article November 6, 2024

Building the Vaccines of the Future

Gladstone's Magnus Hoffmann seeks to advance a new generation of more effective vaccines, improved drug delivery methods, and a greater overall understanding of vaccine-induced immune responses.

COVID-19 Data Science and Biotechnology Infectious Disease

Article November 4, 2024

Brain Immune Cells Amplify Damage Caused by Alzheimer’s Risk Gene, Study Finds

Transplanting human neurons into mouse brains reveals disease-causing interactions between the APOE4 protein and immune cells.

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab

Article October 30, 2024

Using Human Stem Cells, Genomics, and AI to Solve Childhood Heart Disease

A new collaboration between Gladstone Institutes and Murdoch Children’s Research Institute to accelerate life-saving therapies for children affected by heart disease.

Institutional News Cardiovascular Disease

Article October 23, 2024

Gladstone Researchers Discover How Chronic Inflammation Worsens Heart Failure

The new findings have implications for developing immune therapies that target heart disease and chronic conditions in other organs.

News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab